Experience From the Italian S-ICD Registry
ELISIR
Experience From the Long-term Italian Subcutaneous Implantable Cardioverter Defibrillator Registry (ELISIR)
1 other identifier
observational
500
4 countries
18
Brief Summary
The purpose of this registry is to collect data on implant parameters, early, mid and long-term clinical effectiveness of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) therapies in order to better understand how to improve the clinical care of patients and effectiveness of S-ICD therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 13, 2021
April 1, 2021
2.9 years
April 30, 2020
April 10, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Mortality
Overall or arrhythmic mortality
2 years
Appropriate shocks
Appropriate therapies delivered by the devices
2 years
Inappropriate shocks
Inappropriate therapies delivered by the devices
2 years
Interventions
Patients implanted with a totally subcutaneous defibrillator system
Eligibility Criteria
Patients with S-ICD implanted for primary or secondary prevention of sudden cardiac death
You may qualify if:
- Age \>/= 18 years
- Patients successfully implanted with S-ICD
- Patients able to provide written informed consent or have informed consent as provided by a legal representative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
Pitié-Salpêtrière University Hospital
Paris, 75013, France
Asklepios Klinik St. Georg
Hamburg, 20099, Germany
Azienda Sanitaria Provinciale di Cosenza "Ospedale di Castrovillari"
Castrovillari, Cosenza, 87012, Italy
Presidio Ospedaliero Di Anzio e Nettuno
Anzio, Rome, 00042, Italy
Presidio Ospedaliero G. B. Grassi
Lido di Ostia, Rome, 00122, Italy
Presidio Ospedaliero G. Salesi
Ancona, 60123, Italy
Policlinico Sant'Orsola-Malpighi
Bologna, 40138, Italy
Spedali Civili di Brescia
Brescia, 25123, Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, 50139, Italy
Ospedale Vito Fazzi
Lecce, 73100, Italy
Centro Cardiologico Monzino, IRCCS
Milan, 20100, Italy
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
Ospedale Luigi Sacco - Polo Universitario
Milan, 20157, Italy
Ospedale San Gerardo
Monza, 20900, Italy
Policlinico Universitario Campus Bio-Medico
Rome, 00128, Italy
Ospedale San Filippo Neri
Rome, 00135, Italy
Policlinico Umberto I
Rome, 00161, Italy
University Hospital of Zürich
Zurich, 8091, Switzerland
Related Publications (3)
Gulletta S, Gasperetti A, Schiavone M, Vogler J, Fastenrath F, Breitenstein A, Laredo M, Palmisano P, Mitacchione G, Compagnucci P, Kaiser L, Hakmi S, Angeletti A, De Bonis S, Picarelli F, Arosio R, Casella M, Steffel J, Fierro N, Guarracini F, Santini L, Pignalberi C, Piro A, Lavalle C, Pisano E, Viecca M, Curnis A, Badenco N, Ricciardi D, Dello Russo A, Tondo C, Kuschyk J, Della Bella P, Biffi M, Forleo GB, Tilz R. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry. Heart Rhythm. 2022 Jul;19(7):1109-1115. doi: 10.1016/j.hrthm.2022.02.029. Epub 2022 Mar 5.
PMID: 35257974DERIVEDForleo GB, Gasperetti A, Breitenstein A, Laredo M, Schiavone M, Ziacchi M, Vogler J, Ricciardi D, Palmisano P, Piro A, Compagnucci P, Waintraub X, Mitacchione G, Carrassa G, Russo G, De Bonis S, Angeletti A, Bisignani A, Picarelli F, Casella M, Bressi E, Rovaris G, Calo L, Santini L, Pignalberi C, Lavalle C, Viecca M, Pisano E, Olivotto I, Curnis A, Dello Russo A, Tondo C, Love CJ, Di Biase L, Steffel J, Tilz R, Badenco N, Biffi M. Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study. Heart Rhythm. 2021 Dec;18(12):2072-2079. doi: 10.1016/j.hrthm.2021.06.1201. Epub 2021 Jun 30.
PMID: 34214647DERIVEDRicciardi D, Ziacchi M, Gasperetti A, Schiavone M, Picarelli F, Diemberger I, Bontempi L, Di Belardino N, Bisignani G, De Bonis S, Mitacchione G, Calabrese V, Lavalle C, Piro A, Pignalberi C, Santini L, Grigioni F, Tondo C, Biffi M, Forleo GB. Clinical impact of defibrillation testing in a real-world S-ICD population: Data from the ELISIR registry. J Cardiovasc Electrophysiol. 2021 Feb;32(2):468-476. doi: 10.1111/jce.14833. Epub 2020 Dec 18.
PMID: 33296533DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Section head electrophysiology and cardiac pacing
Study Record Dates
First Submitted
April 30, 2020
First Posted
May 5, 2020
Study Start
January 1, 2020
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
April 13, 2021
Record last verified: 2021-04